Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan

Oncogene

Volumn 25, Issue 22, 2006, Pages 3150-3159

  Calvet, L ^a   Geoerger, B ^a   Regairaz, M ^a   Opolon, P ^a   Machet, L ^a   Morizet, J ^a   Joseph, J M ^b   Elie, N ^a   Vassal, G ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiogenesis; CPT 11; Neuroblastoma; Pleiotrophin; Resistance

Indexed keywords

ANGIOSTATIC PROTEIN; COMPLEMENTARY DNA; DNA TOPOISOMERASE INHIBITOR; FIBROBLAST GROWTH FACTOR; IRINOTECAN; PLEIOTROPHIN;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CANCER MODEL; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG SENSITIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VASCULARIZATION; XENOGRAFT;

ANIMALS; CAMPTOTHECIN; CARRIER PROTEINS; CHILD, PRESCHOOL; CYTOKINES; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33745100448     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209348     Document Type: Article

References (46)

1. Blaney S, Berg SL, Pratt C, Weitman S, Sullivan J, Luchtman-Jones L et al. (2001). Clin Cancer Res 7: 32-37.
2. Bourhis J, Benard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G. (1989). J Natl Cancer Inst 81: 1401-1405.
3. Bowden ET, Stoica GE, Wellstein A. (2002). J Biol Chem 277: 35862-35868.
4. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. (1984). Science 224: 1121-1124.
5. Brummelkamp TR, Bernards R, Agami R. (2002). Science 296: 550-553.
6. Calvet L, Santos A, Valent A, Terrier-Lacombe MJ, Opolon P, Merlin JL et al. (2004). Br J Cancer 91: 1205-1212.
7. Chauhan AK, Li YS, Deuel TF. (1993). Proc Natl Acad Sci USA 90: 679-682.
8. Choudhuri R, Zhang HT, Donnini S, Ziehe M, Bicknell R. (1997). Cancer Res 57: 1814-1819.
9. Corbley MJ. (1997). J Biol Chem 272: 24696-24702.
10. Courty J, Dauchel MC, Caruelle D, Perderiset M, Barritault D. (1991). Biochem Biophys Res Commun 180: 145-151.
11. Czubayko F, Schulte AM, Berchem GJ, Wellstein A. (1996). Proc Natl Acad Sci USA 93: 14753-14758.
12. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY. (2002). Arch Biochem Biophys 397: 162-171.
13. Elie N, Plancoulaine B, Signolle JP, Herlin P. (2003). Cytometry A 56: 37-45.
14. Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A. (1992). J Biol Chem 267: 25889-25897.
15. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE et al. (1989). Proc Natl Acad Sci USA 86: 3753-3757.
16. Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC et al. (1999). J Clin Oncol 17: 1815-1824.
17. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H et al. (1989). Cancer 63: 126-132.
18. Herbst RS, Takeuchi H, Teicher BA. (1998). Cancer Chemother Pharmacol 41: 497-504.
19. Heroult M, Bernard-Pierrot I, Delbe J, Hamma-Kourbali Y, Katsoris P, Barritault D et al. (2004). Oncogene 23: 1745-1753.
20. Jain RK. (2005). Science 307: 58-62.
21. Kadomatsu K, Muramatsu T. (2004). Cancer Lett 204: 127-143.
22. Kim NT, Elie N, Plancoulaine B, Herlin P, Coster M. (2003). Anal Cell Pathol 25: 63-75.
23. Komuro H, Li P, Tsuchida Y, Yokomori K, Nakajima K, Aoyama T et al. (1994). Med Pediatr Oncol 23: 487-492.
24. Laaroubi K, Delbe J, Vacherot F, Desgranges P, Tardieu M, Jaye M et al. (1994). Growth Factors 10: 89-98.
25. Li XG, Haluska Jr P, Hsiang YH, Bharti A, Kufe DW, Rubin EH. (1996). Ann NY Acad Sci 803: 111-127.
26. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM et al. (1990). Science 250: 1690-1694.
27. Liu R, Page C, Beidler DR, Wicha MS, Nunez G. (1999). Am J Pathol 155: 1861-1867.
28. Lock RB, Stribinskiene L. (1996). Cancer Res 56: 4006-4012.
29. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC et al. (1991). J Clin Oncol 9: 581-591.
30. Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR, Deuel TF. (1989). Biochem Biophys Res Commun 165: 1096-1103.
31. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A et al. (1995). Cancer Res 55: 1792-1797.
32. Papadimitriou E, Polykratis A, Courty J, Koolwijk P, Heroult M, Katsoris P. (2001). Biochem Biophys Res Commun 282: 306-313.
33. Polykratis A, Delbe J, Courty J, Papadimitriou E, Katsoris P. (2004). Int J Biochem Cell Biol 36: 1954-1966.
34. Rauvala H. (1989). EMBO J 8: 2933-2941.
35. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL et al. (1999). Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. National Cancer institut, SEER Program.
36. Rubin EH, Li TK, Duann P, Liu LF. (1996). Cancer Treat Res 87: 243-260.
37. Schmitt CA, Rosenthal CT, Lowe SW. (2000). Nat Med 6: 1029-1035.
38. Teicher BA, Dupuis NP, Robinson MF, Emi Y, Goff DA. (1995). Oncol Res 7: 237-243.
39. Teicher BA, Herman TS, Holden SA, Wang YY, Pfeffer MR, Crawford JW et al. (1990). Science 247: 1457-1461.
40. Thompson J, Zamboni WC, Cheshire PJ, Lutz L, Luo X, Li Y et al. (1997a). Clin Cancer Res 3: 423-431.
41. Thompson J, Zamboni WC, Cheshire PJ, Richmond L, Luo X, Houghton JA et al. (1997b). Anticancer Drugs 8: 313-322.
42. Vassal G, Doz F, Frappaz D, Gentet JC, Pichon F, Chastagner P et al. (2002). Med Pediatr Oncol (Int Soc Pediatr Oncol, Meet) 39: 257.
43. Vassal G, Doz F, Frappaz D, Imadalou K, Sicard E, Santos A et al. (2003). J Clin Oncol 21: 3844-3852.
44. Vassal G, Pondarre C, Cappelli C, Terrier-Lacombe MJ, Boland I, Morizet J et al. (1997). Eur J Cancer 33: 2011-2015.
45. Vassal G, Terrier-Lacombe MJ, Bissery MC, Venuat AM, Gyergyay F, Benard J et al. (1996). Br J Cancer 74: 537-545.
46. Wildiers H, Guetens G, De Boeck G, Verbeken E, Landuyt B, Landuyt W et al. (2003). Br J Cancer 88: 1979-1986.